ES2090345T3 - Derivados de 3-(pirazoil sustituido en posicion 1)-2-oxindol. - Google Patents

Derivados de 3-(pirazoil sustituido en posicion 1)-2-oxindol.

Info

Publication number
ES2090345T3
ES2090345T3 ES91913692T ES91913692T ES2090345T3 ES 2090345 T3 ES2090345 T3 ES 2090345T3 ES 91913692 T ES91913692 T ES 91913692T ES 91913692 T ES91913692 T ES 91913692T ES 2090345 T3 ES2090345 T3 ES 2090345T3
Authority
ES
Spain
Prior art keywords
derivatives
substituted
sintasa
pirazoil
oxindol
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91913692T
Other languages
English (en)
Inventor
Carl Joseph Goddard
Gary Richard Schulte
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
PFIZER
Pfizer Inc
Original Assignee
PFIZER
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PFIZER, Pfizer Inc filed Critical PFIZER
Application granted granted Critical
Publication of ES2090345T3 publication Critical patent/ES2090345T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

LA INVENCION ESTA RELACIONADA CON DERIVADOS DE 3 AZOIL SUBSTITUIDO) STAGLANDINA H2 SINTASA, LA 5 ES COMO INHIBIDORES DE LA PROSTAGLANDINA H2 SINTASA Y DE LA BIOSINTESIS DE LA INTERLEUCINA-1, PER SE, Y COMO AGENTES ANALGESICOS, ANTIINFLAMATORIOS Y ANTIARTRITICOS EN EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS CRONICAS. ESTA INVENCION TAMBIEN ESTA RELACIONADA CON COMPOSICIONES FARMACEUTICAS QUE COMPRENDEN DICHOS DERIVADOS DE 3 OL; CON METODOS DE INHIBICION DE LA PROSTAGLANDINA H2 SINTASA Y LA BIOSINTESIS DE LA INTERLEUCINA-1; Y CON EL TRATAMIENTO DE ENFERMEDADES INFLAMATORIAS CRONICAS EN UN MAMIFERO CON DICHOS COMPUESTOS. ADEMAS, ESTA INVENCION ESTA RELACIONADA CON CIERTOS COMPUESTOS NUEVOS UTILES COMO COMPUESTOS INTERMEDIOS EN LA PREPARACION DE LOS DERIVADOS DE 3 ON DE LOS DERIVADOS DE 3 DOL.
ES91913692T 1990-07-24 1991-06-12 Derivados de 3-(pirazoil sustituido en posicion 1)-2-oxindol. Expired - Lifetime ES2090345T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/557,265 US5064851A (en) 1990-07-24 1990-07-24 3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use

Publications (1)

Publication Number Publication Date
ES2090345T3 true ES2090345T3 (es) 1996-10-16

Family

ID=24224706

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91913692T Expired - Lifetime ES2090345T3 (es) 1990-07-24 1991-06-12 Derivados de 3-(pirazoil sustituido en posicion 1)-2-oxindol.

Country Status (13)

Country Link
US (1) US5064851A (es)
EP (1) EP0540614B1 (es)
JP (1) JP2504659B2 (es)
AT (1) ATE141601T1 (es)
CA (1) CA2086432C (es)
DE (1) DE69121571T2 (es)
DK (1) DK0540614T3 (es)
ES (1) ES2090345T3 (es)
FI (1) FI107609B (es)
GR (1) GR3021291T3 (es)
IE (1) IE74689B1 (es)
PT (1) PT98404B (es)
WO (1) WO1992001684A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5698399A (en) * 1996-04-05 1997-12-16 Duff; Gordon W. Detecting genetic predisposition for osteoporosis
ID21775A (id) * 1996-10-25 1999-07-22 Yoshitomi Pharmaceutical Senyawa-senyawa 1-fenilpirazol dan penggunaan farmasinya
EP1270565B1 (en) * 1997-01-29 2004-06-30 Pfizer Inc. 4-Substituted furan-2-sulfonamide and its use in the preparation of sulfonyl urea derivatives
DK1270565T3 (da) * 1997-01-29 2004-10-04 Pfizer 4-substitueret furan-2-sulfonamid og dets anvendelse i fremstillingen af sulfonylurinstofderivater
CA2327185A1 (en) * 1998-04-08 1999-10-14 Abbott Laboratories Pyrazole inhibitors of cytokine production
JP4847664B2 (ja) * 2000-01-20 2011-12-28 ノーテル・ネットワークス・リミテッド 高速データを伝送する可変速度無線チャネルのためのフレーム構造
CN107233337A (zh) 2009-04-29 2017-10-10 阿马里纳药物爱尔兰有限公司 含有epa和心血管剂的药物组合物以及使用其的方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3259622A (en) * 1962-09-07 1966-07-05 Merck & Co Inc 1-benzyl-3-indolyl-alpha-haloalkyl and alkylidenyl acetic acids
DE3310891A1 (de) * 1983-03-25 1984-09-27 Boehringer Mannheim Gmbh, 6800 Mannheim Neue indolinon-(2)-derivate, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel und zwischenprodukte
US4556672A (en) * 1984-03-19 1985-12-03 Pfizer Inc. 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
US4569942A (en) * 1984-05-04 1986-02-11 Pfizer Inc. N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
US4861794A (en) * 1988-04-13 1989-08-29 Pfizer Inc. 3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US5047554A (en) * 1989-04-18 1991-09-10 Pfizer Inc. 3-substituted-2-oxindole derivatives

Also Published As

Publication number Publication date
JPH05504773A (ja) 1993-07-22
DE69121571D1 (de) 1996-09-26
PT98404B (pt) 1999-01-29
US5064851A (en) 1991-11-12
WO1992001684A1 (en) 1992-02-06
CA2086432C (en) 1997-12-16
DK0540614T3 (da) 1996-09-09
EP0540614A1 (en) 1993-05-12
JP2504659B2 (ja) 1996-06-05
FI930263L (fi) 1993-01-22
DE69121571T2 (de) 1997-01-09
FI930263A0 (fi) 1993-01-22
IE912574A1 (en) 1992-01-29
ATE141601T1 (de) 1996-09-15
EP0540614B1 (en) 1996-08-21
CA2086432A1 (en) 1992-01-25
IE74689B1 (en) 1997-07-30
GR3021291T3 (en) 1997-01-31
PT98404A (pt) 1992-05-29
FI107609B (fi) 2001-09-14

Similar Documents

Publication Publication Date Title
CO4930259A1 (es) Derivados 6,6-heterobiciclicos sustituidos y composiciones farmaceuticas que los contienen
AR008377A1 (es) Un compuesto derivado de la 3-aroilbencilpiridazinona, una composicion farmaceutica particularmente para el tratamiento de enfermedades inflamatorias o autoinmunes que contiene dicho compuesto
UY26817A1 (es) Agentes antiinflamatorios selectivos de glucocorticoides
GT199800180A (es) Derivados de la tienopirimidina y de la tienopiridina utiles como agentes anticancerigenos.
ES2137486T3 (es) Derivados de 9-hidroxi-pirido(1,2-a)pirimidin-4-ona-eter.
ES2147739T3 (es) Fosfonooximetil-eteres de derivados de taxano.
FR2361383A1 (fr) Derives de tetrahydrocannabinols
ES2068334T3 (es) Derivados 3-sustituidos de 2-oxindoles como agentes antiinflamatorios.
ATE306261T1 (de) Antithrombosemittel
LV5618A3 (lv) Panemiens 2-oksoindol-1-karboksamida atvasinajumu iegusanai
ITMI920528A1 (it) 14-beta idrossi-10-deacetil-baccatina iii, suoi derivati, loro prepazione ed impiego terapeutico
PA8472301A1 (es) Derivados de isotiazol utiles como agentes anticancerosos
ES2192213T3 (es) Arilalquil-diazinonas como inhibidores de fosfodiesterasa iv.
BR9710737A (pt) Pentafluorobenzenosulfonamidas e análogos.
EP0738152A4 (en) USE OF 2-HYDROXY-5-PHENYLAZOBOIC ACID DERIVATIVES AS ACTIVE SUBSTANCES FOR CHEMOPREVENTION AND CHEMOTHERAPY OF COLON CANCER
TR200002345T2 (tr) Glukokortikoit seçiçi antienflamatuar ajanlar
DK599789A (da) 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,3,4-thiadazoler og -oxadiazoler samt 3,5-di-tertiaer-butyl-4-hydroxyphenyl-1,2,4-thiadazoler, -oxadiazoler og -triazoler som anti-inflammatoriske midler
ES2127524T3 (es) Derivados de benzamida como antagonistas de vasopresina.
MX9200396A (es) Derivados de benciloxifenilo, procedimiento para su preparacion y composicion farmaceutica que los contiene.
ES2121084T3 (es) Utilizacion de derivados de terfenadina como antihistaminicos en un paciente que padece de trastornos hepaticos.
ES2043665T3 (es) 6,11-dihidro-11-(4-piperidiliden)-5h-benzo-(5,6)-ciclohepta-(1,2-b)-piridinas y composiciones y metodos de uso.
ES2055867T3 (es) Derivados de dibenzotiazepina utiles como agentes antiespasmodicos.
ES2159054T3 (es) Compuestos di-terc-butil-fenolicos que contienen azufre utiles como agentes antiinflamatorios.
UA41350C2 (uk) Похідна морфоліну або її фармацевтично прийнятна сіль та фармацевтична композиція на її основі
ES482075A1 (es) Procedimiento para la preparacion de carbonilaminofenoxilicosustituidos con biciclo -3.1.0-hexilo.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 540614

Country of ref document: ES

FG2A Definitive protection

Ref document number: 540614

Country of ref document: ES